AU766198B2 - Fulvic acid and its use in the treatment of various conditions - Google Patents

Fulvic acid and its use in the treatment of various conditions Download PDF

Info

Publication number
AU766198B2
AU766198B2 AU59923/99A AU5992399A AU766198B2 AU 766198 B2 AU766198 B2 AU 766198B2 AU 59923/99 A AU59923/99 A AU 59923/99A AU 5992399 A AU5992399 A AU 5992399A AU 766198 B2 AU766198 B2 AU 766198B2
Authority
AU
Australia
Prior art keywords
acid
oxifulvic
derivative
salt
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59923/99A
Other languages
English (en)
Other versions
AU5992399A (en
Inventor
Johannes Dekker
Constance Elizabeth Medlen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfeinsmith Ltd
Original Assignee
Enerkom Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enerkom Pty Ltd filed Critical Enerkom Pty Ltd
Publication of AU5992399A publication Critical patent/AU5992399A/en
Application granted granted Critical
Publication of AU766198B2 publication Critical patent/AU766198B2/en
Assigned to PFEINSMITH LIMITED reassignment PFEINSMITH LIMITED Alteration of Name(s) in Register under S187 Assignors: ENERKOM (PROPRIETARY) LIMITED
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU59923/99A 1998-10-08 1999-10-08 Fulvic acid and its use in the treatment of various conditions Ceased AU766198B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ZA98/9190 1998-10-08
ZA989190 1998-10-08
ZA992848 1999-04-21
ZA99/2848 1999-04-21
PCT/IB1999/001649 WO2000019999A1 (en) 1998-10-08 1999-10-08 Fulvic acid and its use in the treatment of various conditions

Publications (2)

Publication Number Publication Date
AU5992399A AU5992399A (en) 2000-04-26
AU766198B2 true AU766198B2 (en) 2003-10-09

Family

ID=27144980

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59923/99A Ceased AU766198B2 (en) 1998-10-08 1999-10-08 Fulvic acid and its use in the treatment of various conditions

Country Status (7)

Country Link
US (1) US6569900B1 (enExample)
EP (4) EP1126837B1 (enExample)
JP (1) JP4700808B2 (enExample)
AT (4) ATE410160T1 (enExample)
AU (1) AU766198B2 (enExample)
DE (4) DE69932939T2 (enExample)
WO (1) WO2000019999A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1797190B1 (en) * 2004-06-23 2010-10-27 Lone Knight Limited Method for extracting fulvic acid molecules
RU2280458C1 (ru) * 2004-11-30 2006-07-27 Алевтина Ивановна Косолапова Противовоспалительная мазь
WO2006064449A1 (en) * 2004-12-15 2006-06-22 Van Der Westhuizen Cornelis Fl Detoxifying and immunity-booster composition
JP2006232785A (ja) * 2005-02-28 2006-09-07 Univ Of Tsukuba フルボ酸を用いるｉ型アレルギー抑制剤及びｉ型アレルギーの発症抑制方法。
US20080160111A1 (en) * 2005-02-28 2008-07-03 Hiroko Isoda Type I Allergy Inhibitor and Methods of Inhibiting the Onset of Type I Allergy Using Fulvic Acid
US20070212434A1 (en) * 2006-03-07 2007-09-13 Day Kenneth S Compositions and methods for human use containing fulvic acid
CN101437509B (zh) 2006-05-02 2012-03-14 皮费恩史密斯有限公司 酸性组合物
CN102099027B (zh) 2008-06-05 2012-12-12 皮费恩史密斯有限公司 富里酸及抗生素组合物
DE102008058552A1 (de) 2008-11-21 2010-05-27 Mankau, Dieter, Prof. Dr. Federrahmen und Federkörper zur Abstützung z. B. einer Matratze
GB0900786D0 (en) 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
GB0914966D0 (en) 2009-08-27 2009-09-30 Natracine Uk Ltd Fulvic acid compositions and their use
WO2013023062A1 (en) * 2011-08-09 2013-02-14 Wilford Lynn C Antimicrobial agents and methods for use thereof in the abatement of food borne pathogenic organisms
EP2822551B1 (en) 2012-03-07 2016-12-21 Natracine UK Limited Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria
EP3004069B1 (en) 2013-05-28 2017-04-19 Empire Technology Development LLC Humic acid derivatives and methods of preparation and use
EP3004070B1 (en) 2013-05-28 2017-10-11 Empire Technology Development LLC Antioxidant humic acid derivatives and methods of preparation and use
EP3013367B1 (en) 2013-06-28 2018-01-17 Empire Technology Development LLC Edible plasticizers for food and food packaging films
WO2017102565A1 (en) * 2015-12-15 2017-06-22 Rita Dobmeyer Pharmaceutical composition comprising a fulvic acid and at least one boron-containing compound
US9820953B2 (en) 2016-02-26 2017-11-21 Omni Bioceutical Innovations, Inc. Compositions of bioactive fulvate fractions and uses thereof
JP6120342B1 (ja) * 2016-03-08 2017-04-26 株式会社スタイルアンドバリュージャパン 美容組成物
US20220160649A1 (en) * 2019-03-20 2022-05-26 Rita DOBMEYER Pharmaceutical composition
EP3799854A1 (en) 2019-10-01 2021-04-07 Stefan Johannes Fellner Extract of organic humified materials
US20230165918A1 (en) * 2020-05-05 2023-06-01 Figene, Llc Reduction of cytokine storm and pathological inflammation including caused by coronavirus using sphagnum and extracts thereof
KR102258006B1 (ko) * 2020-12-22 2021-05-28 허교 풀빅산을 유효성분으로 포함하는 항바이러스 조성물
CN117064913A (zh) * 2023-02-23 2023-11-17 单士军 用于缓解特应性皮炎的黄腐酸外用制剂

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2850685A1 (de) * 1978-11-22 1980-06-04 Kneer Franz X Verfahren zur herstellung eines kolloiden schlammbades und schlammartiger pasten fuer die heilbehandlung
GB2244215A (en) * 1990-05-25 1991-11-27 Nat Energy Council Bacteriostatic and bactericidal composition
JPH0687752A (ja) * 1992-09-04 1994-03-29 Kyowa Kagaku Kogyo Kk 抗菌水及びこの抗菌水の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB244215A (en) 1924-10-09 1925-12-17 Richard William Bailey Improvements in or relating to gas or oil power plant
JPH0466508A (ja) * 1990-07-03 1992-03-02 Suntory Ltd 抗菌剤
CN1097990A (zh) * 1994-01-29 1995-02-01 康宏盛 一种治疗股癣的药物
JPH1017483A (ja) * 1996-06-26 1998-01-20 Keinzu Corp:Kk 皮膚疾患予防及び治療剤
TR199802702T2 (xx) * 1996-06-27 1999-05-21 Organoflo (Proprietary) Limited Bir s�v� verim artt�rma maddesinin yap�lmas� i�in bir y�ntem.
JPH119674A (ja) * 1997-06-25 1999-01-19 M S K Planning:Kk フミン酸を有効成分とする液体消臭剤と、その製造方法及びフミン酸を有効成分とした飲料用消臭剤と、その製造方法
CN1103339C (zh) * 1998-08-25 2003-03-19 祝亚勤 药用级泥炭黄腐植酸钠的制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2850685A1 (de) * 1978-11-22 1980-06-04 Kneer Franz X Verfahren zur herstellung eines kolloiden schlammbades und schlammartiger pasten fuer die heilbehandlung
GB2244215A (en) * 1990-05-25 1991-11-27 Nat Energy Council Bacteriostatic and bactericidal composition
JPH0687752A (ja) * 1992-09-04 1994-03-29 Kyowa Kagaku Kogyo Kk 抗菌水及びこの抗菌水の製造方法

Also Published As

Publication number Publication date
EP1126837B1 (en) 2006-08-23
DE69939720D1 (de) 2008-11-20
US6569900B1 (en) 2003-05-27
EP1698333A1 (en) 2006-09-06
JP4700808B2 (ja) 2011-06-15
ATE410158T1 (de) 2008-10-15
ATE336997T1 (de) 2006-09-15
AU5992399A (en) 2000-04-26
EP1700600B1 (en) 2008-10-08
JP2002526407A (ja) 2002-08-20
DE69939722D1 (de) 2008-11-20
ATE410159T1 (de) 2008-10-15
DE69939721D1 (de) 2008-11-20
DE69932939T2 (de) 2006-12-07
ATE410160T1 (de) 2008-10-15
EP1700599B1 (en) 2008-10-08
EP1700600A1 (en) 2006-09-13
EP1126837A1 (en) 2001-08-29
WO2000019999A1 (en) 2000-04-13
EP1698333B1 (en) 2008-10-08
EP1700599A1 (en) 2006-09-13
DE69932939D1 (de) 2006-10-05

Similar Documents

Publication Publication Date Title
AU766198B2 (en) Fulvic acid and its use in the treatment of various conditions
US6709681B2 (en) Acidified nitrite as an antimicrobial agent
DE69532921T2 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
US4049802A (en) Zinc sulfadiazine and its use in the treatment of burns
JPH09501702A (ja) 増強された抗生物質組成物
EP0463190B1 (en) Minerals in bioavailable form
US4873265A (en) Anti-infective methods and compositions
Islam et al. Stem extract of Albizia richardiana exhibits potent antioxidant, cytotoxic, antimicrobial, anti-inflammatory and thrombolytic effects through in vitro approach
WO1988001509A1 (en) Pharmacologically active compositions of catecholic butanes with zinc
EP0049593A1 (en) 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid and metal salts thereof useful in burn therapy
JP3019996B2 (ja) 白癬治療剤
Harris et al. The development and evaluation of melatonin-loaded, calcium oxide nanoparticle-based neem and clove extract: an in vitro study
JPS61500067A (ja) １−エチル−６−フルオロ−１，４−ジヒドロ−４−オキソ−７−（１−ピペラジニル）−３−キノリンカルボン酸またはその金属塩およびスル
US4929619A (en) Anti-infective methods and compositions
ZA200102419B (en) Fulvic acid and its use in the treatment of various conditions.
JPH09194358A (ja) 多価フェノール誘導体含有抗ｍｒｓａ活性医薬組成物
US4897404A (en) Anti-infective methods and compositions
RU2174004C1 (ru) Средство, обладающее диуретическим, противовоспалительным и дезинфицирующим действием
US4895857A (en) Anti-infective methods and compositions
JP3058659B2 (ja) 生物的に利用可能な形態のミネラル
US4895859A (en) Anti-infective methods and compositions
Hunde et al. An In Vitro Evaluation of the Antibacterial Activity of Aloe barbadensis on Selected Bacterial Strains
Sharma et al. Evaluation of Antioxidant and Antibacterial Activities of Hydroalcoholic Extract of Cassia fistula Bark
WO2025099739A1 (en) A formulation for wound healing management and its method of preparation thereof
DE1915019C3 (de) Mittel und Verfahren zur Behandlung von Dermatophytose

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 14, NO 29, PAGE(S) 5293-5296 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 59923/99

FGA Letters patent sealed or granted (standard patent)